Regan, Meredith M <br/><br/>
Using clinical trial data to tailor adjuvant treatments for individual patients.  [electronic resource] 

 -  Breast (Edinburgh, Scotland)  Dec 2007 
 - S98-104 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0960-9776 
<br/><br/><label>Standard No.: </label>10.1016/j.breast.2007.07.016  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--pharmacology<br/>Antibodies, Monoclonal, Humanized<br/>Antineoplastic Agents--pharmacology<br/>Breast Neoplasms--drug therapy<br/>Chemotherapy, Adjuvant<br/>Clinical Trials as Topic<br/>Female<br/>Humans<br/>Neoplasm Staging<br/>Radiotherapy, Adjuvant<br/>Receptor, ErbB-2--drug effects<br/>Receptors, Estrogen--drug effects<br/>Receptors, Progesterone<br/>Survival Analysis<br/>Trastuzumab<br/>Treatment Outcome